Status:

RECRUITING

A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder

Lead Sponsor:

Shanghai Mental Health Center

Collaborating Sponsors:

Shanghai Mental Health Center, Hongkou District

Shanghai Mental Health Center, Xuhui District

Conditions:

High-risk

Bipolar Disorder

Eligibility:

All Genders

6-18 years

Brief Summary

Bipolar disorder (BD) is a serious, complicated, familial aggregation onset of mental illness, which has the characteristics of five-low and one-high, namely high prevalence, high recurrence rate, hig...

Eligibility Criteria

Inclusion Criteria:

  • High-risk offsprings of parents with BD: Aged 6-18 yrs, both male and female. Offsprings and parents can sign the writtened informed consent form. At least one of parents was diagnosed with bipolar disorder by two or more senior psychiatric doctor.
  • Atypical depression: Aged 6-18 yrs, both male and female. Patients and parents can sign the writtened informed consent form. Patients was diagnosed with atypical depression by two or more senior psychiatric doctor according to DSM-5. The disease phase and treatment regime are unrestricted.
  • Health control: health individuals with age and gender matched with high-risk offsprings, no psychiatric family history.

Exclusion Criteria:

  • High-risk offsprings of parents with BD: HCL-32 total score > 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.
  • Atypical depression: HCL-32 total score > 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. Patients cormobid substance abuse or treated with MECT in recent half a year.
  • Health control: Individuals with psychiatric family history, severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.

Key Trial Info

Start Date :

October 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT07031661

Start Date

October 15 2024

End Date

December 1 2025

Last Update

June 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China, 200030

A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder | DecenTrialz